Parkinsonism & Related Disorders: Volume 70 to Volume 81
Parkinsonism & Related Disorders is a comprehensive journal that publishes research findings from both basic and clinical studies aimed at enhancing the understanding, diagnosis, and treatment of neurodegenerative syndromes involving Parkinsonism, Essential Tremor, and related movement disorders.
The journal covers a wide range of topics within the field, including but not limited to:
- Molecular biology
- Neuroanatomy
- Neurophysiology and electrophysiology
- Neuropharmacology
- Neuropsychology
- Neuroimaging
- Neurotoxicology
- Clinical phenomenology
- Surgical and pharmacological treatment approaches
- Transplantation studies
- Relationship with aging
- Epidemiology and environmental impact factors
- Rehabilitation strategies
Parkinsonism & Related Disorders provides a platform for various types of articles, including:
- Review articles that synthesize and present an overview of recent research in specific areas.
- Point of View articles that offer perspectives on current trends, debates, or emerging issues.
- Full-length articles that present comprehensive research findings and their implications.
- Short communications that report concise yet important research findings.
- Case reports that share unique or notable clinical cases.
- Letters to the Editor that contribute to ongoing discussions or debates.
The journal aims to foster international collaboration and communication between researchers and clinicians in the field of movement disorders, facilitating the exchange of valuable knowledge and advancements. For manuscripts primarily focused on the clinical aspects of movement disorders, authors are directed to submit to Clinical Parkinsonism & Related Disorders.
Volume 70: Pages 1-102 (January 2020)
Volume 71: Pages 1-72 (February 2020)
Volume 72: Pages 1-88 (March 2020)
Volume 73: Pages 1-116 (April 2020)
Volume 74: Pages 1-86 (May 2020)
Volume 75: Pages 1-132 (June 2020)
Volume 76: Pages 1-112 (July 2020)
Volume 77: Pages 1-182 (August 2020)
Volume 78: Pages 1-204 (September 2020)
Volume 79, Supplement 1: Pages e1-e126 (October 2020)
Volume 79: Pages 1-144 (October 2020)
Supplement: Adenosine A2A receptor antagonism in the treatment paradigm of Parkinson’s Disease: The WHY and the HOW?
This article is published as part of a supplement supported by KyowaKirin, Inc
Volume 80, Supplement 1, Pages S1-S64 (November 2020)
Reviews
There are no reviews yet.